Comparison Chart Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	-1.59%	+1.36%	+21.10%	+38.32%	+185.66%	141B

Sep. 02	Evercore ISI Adjusts Vertex Pharmaceuticals Price Target to $600 From $535, Maintains Outperform Rating	MT
Sep. 01	Vertex Pharmaceuticals Incorporated Announces Chief Financial Officer Changes, Effective January 1, 2027	CI

Real-time Estimate Cboe BZX 01:50:09 2026-09-04 pm EDT			5-day change	1st Jan Change
549.10 ^USD	-1.59%		+1.36%	+21.10%

Comparison Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Compared values